Abstract
The intracerebroventricular administration of Zn2+ (0.3 μmol/10 μl) causes epileptic seizures characterized by running fits, jumping, vocalization, fasiculation of facial muscles, myoclonic movements of the limbs and tonic-clonic convulsions. These episodes are blocked or reversed by γ-aminobutyric acid (0.4 μmol/10 μl). When assayed under conditions where pyridoxal phosphate was not added, the activity of glutamic acid decarboxylase decreased significantly in hippocampus from 18.9 to 15.3 and 9.7 μmol14CO2 formed/gram proteins/20 min, 15 and 30 min following administration of Zn2+. The inhibition of glutamic acid decarboxylase by Zn2+ was selective occurring only in hippocampus and not in the hypothalamus, amygdala, caudate or thalamus. The inhibition of glutamic acid decarboxylase was not due to a reduction in the concentration of endogenous pyridoxal phosphate which remained unaltered in hippocampus following Zn2+ administration.
Similar content being viewed by others
References
Roberts, E., Chase, T. N., andTower, D. B. 1976. GABA in Nervous System Function. KROC Fdn. Series Vol. 5, Raven Press, New York.
Morselli, P. L., Lloyd, K. G., Löscher, W., Meldrum, B., andReynolds, E. H. 1981. Neurotransmitters, Seizures and Epilepsy. Raven Press, New York.
VanGelder, N. M., Sherwin, A. L., andRasmussen, T. 1972. Amino acid content of epileptogenic human brain: Focal versus surrounding regions. Brain Res. 40:385–393.
VanGelder, N. M., andCourtois, A. 1972. Close correlation between changing content of specific amino acids in epileptogenic cortex of cats and severity of epilepsy. Brain Res. 43:477–484.
Emson, P. C., andJoseph, M. H. 1975. Neurochemical and morphological changes during the development of cobalt-induced epilepsy in the rat. Brain Res. 93:91–110.
Ribak, C. R., Harris, A. B., Vaughn, J. E., andRoberts, E. 1979. Inhibitory GABAergic nerve terminals decrease at sites of focal epilepsy. Sci. 205:211–214.
Bakay, R. A. E., andHarris, A. B. 1981. Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci. Brain Res. 206:387–404.
Roberts, E., andKuriyama, K. 1968. Biochemical-physiological correlations in studies of the γ-aminobutyric acid. Brain Res. 8:1–35.
Kuriyama, K., Haber, T., Sisken, T., andRoberts, E. 1966. The γ-aminobutyric acid system in rabbit cerebellum. Proc. Nat. Acad. Sci., U.S.A. 55:846–849.
Kuriyama, K., Sisken, T., Haber, B., andRoberts, E. 1968. The γ-aminobutyric acid system in rabbit retina. Brain Res. 9:165–168.
Fonum, F. 1975. The localization of glutamate decarboxylase, choline acetyltransferase and aromatic amino acid decarboxylase in mammalian and invertebrate nervous tissue. Pages 99–122,in Berl, S., Clark, D. D. andSchneider, D. (eds), Metabolic Compartmentation and Neurotransmission, Plenum Press, New York.
Roberts, E., Wein, J., andSimonsen, D. G. 1964. γ-aminobutyric acid (GABA), vitamin B6, and neuronal function—a speculative synthesis. Vitam. Horm. 22:503–559.
Perez De La Mora, M., Feria-Velasco, A., andTapia, R. 1973. Pyridoxal phosphate and glutamate decarboxylase in subcellular particles of mouse brain and their relationship to convulsions. J. Neurochem. 20:1575–1587.
Miller, L. P., Martin, D. L., Mazumder, A., andWaiters, J. P. 1978. Studies on the regulation of GABA synthesis: substrate-promoted dissociation of pyridoxal-5′-phosphate from GAD. J. Neurochem. 30:361–369.
Ebadi, M. 1981. Regulation and function of pyridoxal phosphate in CNS. Neurochem. Int. 3:181–206.
Sytinsky, I. A., Soldatenkov, A. T., andLajtha, A. 1978. Neurochemical basis of the therapeutic effect of γ-aminobutyric acid and its derivatives. Prog. Neurobiol. 10:89–133.
Donaldson, T., St.-Pierre, T., Minnich, J., andBarbeau, A. 1971. Seizures in rats associated with divalent cation inhibition of Na+K+-ATPase. Can. J. Biochem. 49:1217–1224.
Wu, J.-Y., andRoberts, E. 1974. Properties of brainl-glutamate decarboxylase-inhibition studies. J. Neurochem. 23:759–767.
Wu, J.-Y., Wong, E., Saito, K., Roberts, E., andSchousboe, A. 1976. Properties of L-glutamate decarboxylase from brains of adult and newborn mice. J. Neurochem. 27:653–659.
McCormick, D. B., Gregory, M. E., andSnell, E. E. 1961. Pyridoxal phosphokinases—I. Assay, distribution, purification and properties. J. Biol. Chem. 236:2076–2084.
Neary, J. T., andDiven, W. F. 1970. Purification, properties and a possible mechanism for pyridoxal kinase from bovine brain. J. Biol. Chem. 245:5585–5593.
Ebadi, M., Itoh, M., Bifano, J., Wendt, K., andEarle, A. 1981. The role of Zn++ in pyridoxal phosphate mediated regulation of glutamic acid decarboxylase in brain. Int. J. Biochem. 13:1107–1112.
Itoh, M., andEbadi, M. 1981. The selective inhibition of glutamic acid decarboxylase (GAD) in hippocampus by Zn++. Pharmacologist 23:243.
Sundaresan, P. R., andCoursin, D. B. 1970. Microassay of pyridoxal phosphate usingl-tyrosine-[14C] and tyrosine apodecarboxylase. Pages 509–512,in McCormick, D. B. andWright, L. B. (eds) Methods in Enzymology, Vol. 18, Academic Press, New York.
Bhagavan, H. M., Koogler, H. M. Jr. andCoursin, D. B. 1976. Enzymatic microassay of pyridoxal-5-phosphate using L-tyrosine apodecarboxylase andl-[1-14C]tyrosine. Int. J. Vitam. Nutr. Res. 46:160–164.
Smeyers-Verbeke, J., DeFrise-Gussenhoven, E., Ebinger, G., Lowenthal, A., andMassart, D. L. 1974. Distribution of Cu and Zn in human brain tissue. Clinica Chim. Acta 51:309–314.
Wuyts, L., Smeyers-Verbeke, J., andMassart, D. L. 1976. Atomic absorption spectrophotometry of copper and zinc in human brain tissue. A critical investigation of two digestion techniques. Clinica. Chim. Acta 72:405–407.
Noble, E. P., Wurtman, R. J., andAxelrod, J. 1967. A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain. Life Sci. 6:281–291.
Glowinski, J., andIversen, L. L. 1966. Regional studies of catecholamines in the rat brain—I. The disposition of [3H] norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 13:655–669.
König, F. R., andKlippel, R. A. 1963. The Rat Brain. William and Wilkins, Baltimore.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., andRandall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Armitage, P. 1971. Statistical Methods in Medical Research. Wiley, New York.
Storm-Mathisen, J. 1972. Glutamate decarboxylase in the rat hippocampal region after lesions of the afferent fibre systems. Brain Res. 40:215–235.
Andersen, P., Eccles, J. C., andLøyning, Y. 1964. Pathways of postsynaptic inhibition in the hippocampus. J. Neurophysiol. 27:608.
Biscoe, T. J., andStraughan, D. W. 1966. Micro-electrophoretic studies of neurones in the cat hippocampus. J. Physiol. (Lond.) 183:341.
Curtis, D. R., Felix, D., andMcLennan, H. 1970. GABA and hippocampal inhibition. Br. J. Pharmacol. 40:881–883.
Itoh, M., andUchimura, H. 1981. Regional Differences in Cofactor Saturation of Glutamate Decarboxylase (GAD) in Discrete Brain Nuclei of the Rat: Effect of Repeated Administration of Haloperidol on GAD Activity in the Substantia Nigra. Neurochem. Res. 6:1283–1289.
Bayon, A., Possani, L. D., andTapia, R. 1977. Kinetics of brain glutamate decarboxylase—inhibition studies with N-(5′-phosphopyridoxal) amino acids. J. Neurochem. 29:513–517.
Bayon, A., Possani, L. D., Tapia, M., andTapia, R. 1977. Kinetics of brain glutamate decarboxylase. Interactions with glutamate, pyridoxal 5-phosphate and glutamine-pyridoxal 5-phosphate. Schiff base. J. Neurochem. 29:519–525.
Covarrubias, M., andTapia, R. 1980. Brain glutamate decarboxylase: properties of its calcium-dependent binding to liposomes and kinetics of the bound and the free enzyme. J. Neurochem. 34:1682–1688.
Prasad, A. S. 1979. Clinical, biochemical and pharmacological role of zinc. A Rev. Pharmac. Toxic. 20:393–426.
Itoh, M. andEbadi, M. 1982. Zinc binding proteins in rat brain and their interactions with glutamic acid decarboxylase. Fed. Proc. 41:8736.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Itoh, M., Ebadi, M. The selective inhibition of hippocampal glutamic acid decarboxylase in zinc-induced epileptic seizures. Neurochem Res 7, 1287–1298 (1982). https://doi.org/10.1007/BF00965899
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00965899